Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BRANCH-HF
CTR20260259Phase 2Active
- Sponsor
- Pfizer
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PF-07328948 in chronic heart failure (CHF), sponsored by Pfizer. Started May 2026; status: active.
02
Drugs
PF-07328948
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on CTR20260259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260259.